Find Clinical Trial
Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets and micronized purified flavonoid fraction 500 mg tablets after 7 days of treatment followed by a follow-up period of 7 days in patients suffering from acute hemorroidal disease (HD)
← Back
| Study Phase |
Phase 3 |
| Therapeutic Area |
Cardiovascular Diseases |
| Indication | venous disease |
| Sponsor | Institut de Recherches Internationales Servier (I.R.I.S) |
| Active substance/ Medical device |
MICRONISED PURIFIED FLAVONOID FRACTION, |
| Active Substance Code | S005682 |
| Protocol Code | CL3-05682-108 |
| ISRCTN Code | ISRCTN28639953 |
Documents and links
| Results summary | READ MORE  |
| Scientific publication | READ MORE |
Servier Glossary of Terms
To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.
© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility
